0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology

Buy Now

Clinical Use of Antiviral Drugs (Paperback, Softcover reprint of the original 1st ed. 1988) Loot Price: R5,802
Discovery Miles 58 020
Clinical Use of Antiviral Drugs (Paperback, Softcover reprint of the original 1st ed. 1988): Erik De Clercq

Clinical Use of Antiviral Drugs (Paperback, Softcover reprint of the original 1st ed. 1988)

Erik De Clercq

Series: Developments in Medical Virology, 3

 (sign in to rate)
Loot Price R5,802 Discovery Miles 58 020 | Repayment Terms: R544 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Antiviral chemotherapy has come of age, and, after an initial slow pro gress, the development of new antiviral agents has proceeded at a more rapid pace and the perspectives for their clinical use have increased considerably. Now, 25 years after the first antiviral assay (idoxuridine) was introduced in the clinic, it is fitting to commemorate the beginning of the antivirals' era. In its introductory chapter B.E. Juel-Jensen touches on what may be con sidered as five of the most fundamental requirements of an antiviral drug: efficacy, relative non-toxicity, easy solubility, ready availability and rea sonable cost. Surely, the antiviral drugs that have so far been used in the clinic could still be improved upon as one or more of these five essential demands are concerned. How is all began is narrated by W.H. Prusoff. The first antiviral drugs to be used in humans were methisazone and idoxuridine, the former, which is now of archival interest, in the prevention of smallpox, the latter, which was approved for clinical use in the United States in 1962, for the topical treatment of herpetic keratitis. In terms of potency, also because of solubility reasons, idoxuridine has been superseded by trifluridine in the topical treatment of herpes simplex epithelial keratitis. H.E. Kaufman did not find trifluridine or acyclovir ef fective in the treatment of deep stromal keratitis or iritis and he reckons that other antiviral drugs (i.e. bromovinyldeoxyuridine) would not be effec tive either."

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Developments in Medical Virology, 3
Release date: February 2012
First published: 1988
Editors: Erik De Clercq
Dimensions: 235 x 155 x 23mm (L x W x T)
Format: Paperback
Pages: 414
Edition: Softcover reprint of the original 1st ed. 1988
ISBN-13: 978-1-4612-8966-1
Categories: Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology
LSN: 1-4612-8966-1
Barcode: 9781461289661

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners